Variation in Hospital Costs, Payments, and Profitabilty for Cardiac Valve Replacement Surgery

Abstract

Objective. Examine the variation for Medicare and privately insured patients in hospital costs, payments, and contribution margins and their association with characteristics of the patients, hospitals, and hospital markets. Data Sources. Administrative records for 1,858 patients undergoing cardiac valve replacement surgery were obtained from 37 hospitals in 7 states for 2008. Study Design. Bivariate and multivariate statistical analyses of costs, payments, and profitability (contribution margin) for Medicare and privately insured patients, adjusting for patient, hospital, and market characteristics. Data Collection. Integrated Health Care Association, Aspen Health Metrics, American Hospital Association Annual Survey of Hospitals. Principal Findings. Cardiac valve replacement surgery is an expensive but profitable procedure, with average cost and contribution margin per case of U.S.$38,667 and U.S.$21,967, respectively. Average costs per case for Medicare patients are 16.1 percent higher in concentrated than in competitive local markets after adjusting for patient comorbidities, complications, and other relevant factors (p<.01). Payments per case were 33.2 percent (p<.01) lower from Medicare than from private insurers. The average contribution margin earned by hospitals from Medicare was U.S.$30,986 lower than the margin earned from private insurers (p<.01), after adjusting for patient, hospital, and market characteristics. Conclusions. Hospitals charge significantly higher prices and earn significantly higher contribution margins from private insurers than from Medicare for patients undergoing cardiac valve replacement.

Patient and facility variation in costs of catheter ablation for atrial fibrillation

“…This method captures actual costs (not charges), thereby avoiding issues with estimating cost‐to‐charge ratios that are dependent on treatment facility and payer. These methods have been widely applied in health economics assessments for cardiovascular procedures and for AF ablation specifically . We defined ablations as outpatient only if all associated reimbursements were classified as outpatient (“23‐hour stay”) and defined ablations as inpatient if any associated reimbursements were classified as inpatient.…”

“…These methods have been widely applied in health economics assessments for cardiovascular procedures and for AF ablation specifically. [10][11][12][13] We defined ablations as outpatient only if all associated reimbursements were classified as outpatient ("23-hour stay") and defined ablations as inpatient if any associated reimbursements were classified as inpatient. We accounted for inflation by normalizing all dollars to October 2014 using the Medical Care Consumer Price Index.…”

Demographics and clinical and economic characteristics of patients receiving total hip arthroplasty with and without muscle atrophy/weakness

“…Medicare, regulated and funded by the US government, provides insurance coverage for aged (65 years old or older) and disabled persons. Studies have suggested that Medicare generally has a lower reimbursement rate than commercial plans for the same procedure or service 13,14. Because health care costs are the main study outcome, separate analyses on commercially insured and Medicare patients minimize the bias introduced by these different payment rates.…”

Finding the Evidence for Decision Analytic Cost Effectiveness Models

“…By contrast, economic evaluations undertaken in North America will need to draw upon data from the public, private and not-for-profit sectors. For example, in the USA the physician fee component of cost can be obtained from Medicare (CMS 2014 ); however, hospital, test and pharmaceutical costs will often need to be obtained separately and frequently vary according to provider and indeed the payer (Robinson 2011 ). In the USA, Medicare provides increasingly detailed information on costs they incur for a wide range of services (CMS 2012 ).…”